Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
4Customers
2Debt Items
4Related Chains
Source-Backed Evidence Depth
DBV Technologies S.A. (DBVT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
11Total relationships
1Distinct source URLs
3High confidence
0.769Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
DBV Technologies S.A. Suppliers
Ticker
Name
Confidence
Evidence
DBVTF
DBV TECHNOLOGIES
72%
Reciprocal relationship from DBVTF graph: Reciprocal relationship from DBVT graph: Reciprocal relationship from DBVTF graph: e initially classified as equity. Other conditions necessary for equity cl…
DBVTF
DBV TECHNOLOGIES
72%
. cGMP regulations require, among other things, quality control and quality assurance as well as the corresponding maintenance of records and documentation and the obligation to investigate and corre…
SNYNF
Sanofi
72%
the Viaskin patch both biological and chemical substances. Viaskin is a Highly Scalable Manufacturing Technology We currently rely on a single contract manufacturer to manufacture and supply the acti…
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from DBVT graph: the Viaskin patch both biological and chemical substances. Viaskin is a Highly Scalable Manufacturing Technology We …
DBV Technologies S.A. Customers
Ticker
Name
Confidence
Evidence
DBVTF
DBV TECHNOLOGIES
72%
Reciprocal relationship from DBVTF graph: Reciprocal relationship from DBVT graph: l Anti-Kickback Statute was amended by the ACA to a stricter standard such that a person or entity no longer needs t…
DBVTF
DBV TECHNOLOGIES
72%
l Anti-Kickback Statute was amended by the ACA to a stricter standard such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to…
SNYNF
Sanofi
72%
the Viaskin patch both biological and chemical substances. Viaskin is a Highly Scalable Manufacturing Technology We currently rely on a single contract manufacturer to manufacture and supply the acti…
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from DBVT graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from DBVT graph: the Viaskin patch both biological…
DBV Technologies S.A. Debt Obligations
Instrument
Description
Confidence
Evidence
DBVT-DEBT
Debt stack $1.5M
90%
Market cache reports total debt of $1.5M.
DBVT-DEBT-9032
Warrants outstanding: 3.11
90%
xbrl warrant detail from xbrl 2025-12-31.
DBV Technologies S.A. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for DBV Technologies S.A..
DBV Technologies S.A. Ownership
Holder
Name
Confidence
Evidence
DBVT-OWNER-VIVO-CAPITAL-LLC
Vivo Capital, LLC
90%
13F overlay lists Vivo Capital, LLC as top holder; 72 tracked holders.
